Search

everythinglearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Stress-related hair loss was reversed with a special medication.

The conclusion is that the cornea has two types of stem cells, with Lrig1+ cells being key for renewal in aging corneas, independent of CD44.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Severe acne patients have higher inflammatory markers than healthy people.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

COVID-19 infection may trigger alopecia areata in some patients.